Drug profile · INN
prednicarbate
DERMATOP
prednicarbate (DERMATOP) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Drug details — prednicarbate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 6
- Data quality
- 0.84
Quick answer
prednicarbate (DERMATOP) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is prednicarbate?
prednicarbate (DERMATOP) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for prednicarbate?
DERMATOP is a marketed brand name for prednicarbate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of prednicarbate?
prednicarbate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.